Aeon has raised $17.0M in total across 2 funding rounds.
Aeon's investors include 8VC, Accel, Afore Capital, Endeavor Health Ventures, Feenix Ventures, MaC Venture Capital, Andrew Schoen, Dan Wright, Jon Runyan, Nkechi Iregbulem, Browder Capital, Countdown Capital.
Aeon Technology Inc. is a small software company founded in 2000 and headquartered in San Diego, California, specializing in computational chemistry tools.[1] It develops and distributes the Direct Force Field (DFF) software, with its latest version DFF7 serving as both a parameter-fitting engine derived from quantum mechanical data and an extensible force field database covering life sciences and materials science applications.[1] The company targets researchers and scientists in these fields, solving the challenge of accurate molecular simulations by providing comprehensive, adaptable force fields that outperform traditional models in coverage and extensibility.[1] With under 25 employees and annual revenue around $5.1 million, it maintains a niche but steady presence without recent public news of major growth.[1]
(Note: Multiple entities share similar names, such as Aeon Technologies LLC (diagnostics lab founded 2019)[2][4] and Aeon Technology Group (web development agency)[3], but the query's "technology company" description aligns most closely with Aeon Technology Inc.'s software focus.[1])
Aeon Technology Inc. was funded in 2000 in California, emerging as a specialized software developer in the computational chemistry space.[1] Little public detail exists on its founders or key early figures, but the company's evolution centers on long-term research into force field methodologies, culminating in iterative releases like DFF7.[1] This version builds on decades of refinement, transitioning from basic tools to a sophisticated database and engine that integrates quantum data for broader scientific applications, reflecting steady, research-driven progress rather than explosive startup growth.[1]
Aeon Technology rides the wave of computational chemistry and molecular modeling, critical for drug discovery, materials design, and biotech amid rising AI-driven simulations.[1] Its timing leverages advances in quantum computing and high-throughput data, where extensible force fields address gaps in simulating complex systems like proteins or nanomaterials. Market forces favoring it include growing demand for accurate, scalable sims in pharma R&D and sustainable materials—areas exploding post-2020 with AI tools like AlphaFold. Aeon influences the ecosystem subtly by enabling niche research, though its small size limits broader disruption compared to giants like Schrödinger or OpenEye.
Aeon Technology's niche in extensible force fields positions it well for integration with emerging AI/ML-enhanced simulations, potentially accelerating adoption in biotech and materials R&D. Next steps likely involve DFF updates incorporating quantum-AI hybrids or cloud deployment to boost accessibility. As computational tools democratize, its influence could grow via partnerships, evolving from quiet innovator to key enabler in precision science—reinforcing its core strength in bridging quantum data to real-world applications.[1]
Aeon has raised $17.0M across 2 funding rounds. Most recently, it raised $12.0M Seed in March 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2025 | $12.0M Seed | 8VC, Accel, Afore Capital, Endeavor Health Ventures, Feenix Ventures, MaC Venture Capital, Andrew Schoen, Dan Wright, Jon Runyan, Nkechi Iregbulem | |
| Nov 1, 2023 | $5.0M Seed | 8VC, Accel, Afore Capital, Browder Capital, Countdown Capital, Endeavor Health Ventures, Feenix Ventures, Founders Fund, MaC Venture Capital, Andrew Schoen, Preston-Werner Ventures, Ravelin Capital, SignalFire, Aaron Peterman, David Mytton |
